Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
Clinical trial NCT02227914 · WITHDRAWN
Trial details
- NCT number
- NCT02227914
- Sponsor
- Amgen
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-03-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.